Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2026-01-03 @ 12:14 AM
Study NCT ID:
NCT01468467
Status:
COMPLETED
Last Update Posted:
2019-02-12
First Post:
2011-11-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of AC220 Given After Transplant in Subjects With Acute Myeloid Leukemia (AML)
Sponsor:
Daiichi Sankyo
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Leukemia, Myeloid, Acute | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | AC220 | View |
| None | Acute Myeloid Leukemia (AML) | View |
| None | Transplantation | View |
| None | Stem Cell Transplantation | View |
| None | Allogeneic Transplantation | View |
| None | FMS-like tyrosine kinase (FLT3) | View |
| None | FMS-like tyrosine kinase (FLT3) Inhibitor | View |
| None | Kinase | View |
| None | Kinase Inhibitor | View |
| None | Pharmacokinetics | View |
| None | ASP2689 | View |
| None | quizartinib | View |